HIV: open trials in Japan

• NCT07681089

  A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

  Trial Treatment · Phase 2 · Kiminori Kimura, MD

  Tokyo Metropolitan Komagome Hospital, Bunkyo Ku · National Hospital Organization Osaka National Hospital, Osaka · Hokkaido University Hospital, Sapporo · National Hospital Organization Sendai Medical Center, Sendai

  Registry updated 2026-10-05

• NCT07650916

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  Trial Treatment · Phase 3 · ViiV Healthcare

  Aichi · Kanagawa · Osaka · Tokyo

  Registry updated 2026-09-28

• NCT07682961

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  Trial Treatment · Phase 3 · Gilead Sciences

  National Hospital Organization Osaka National Hospital, Osaka

  Registry updated 2026-08-14

• NCT07202546

  A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  Trial Treatment · Phase 2 · ViiV Healthcare

  Fukuoka · Kanagawa · Okinawa · Osaka · Tokyo

  Registry updated 2026-07-23

All HIV trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error